Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Royal Society Africa Prize 2021 is awarded to Professor George Warimwe for his work on zoonoses vaccine development, capacity building in Africa, and his innovative research proposal. This Prize recognises research scientists based in Africa who are making an innovative contribution to the sciences.

George Warimwe

Professor George Warimwe works on various viral infections that are transmitted between humans and animals in Africa with a focus on vaccine development for their control. His vaccine programmes exploit synergies in human and livestock immunology to accelerate development of candidate vaccines for deployment in humans and the respective animal hosts of infection.

Using this approach, Professor Warimwe has developed ChAdOx1 RVF, a novel chimpanzee adenovirus vectored Rift Valley Fever vaccine, that is highly efficacious in multiple target livestock species (sheep, goats, cattle) and is currently in human phase I clinical trials. Read the publication Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats on the Nature website

The full story is available on The Royal Society website